You may have heard that there’s a new Omicron spinoff that’s quickly gaining ground in the United States. Maybe you wanted to ask your doctor about it or search for more information online – but what ...
In a recent study posted to the medRxiv* preprint server, researchers longitudinally followed up hospitalized (H) and non-hospitalized (NH) coronavirus disease 2019 (COVID-19) patients six months ...
Sanofi SA and GSK plc said new phase III data show their adjuvanted bivalent D614 and beta (B.1.351) COVID-19 vaccine candidate responded well against omicron despite it being designed to fight the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results